Articles From: Husky Energy Announces 2014 Second Quarter Dividend to IRIDEX Announces Second Quarter 2014 Conference Call and Release Date


http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0959021001&sourceType=1 http://www.ccnmatthews.com/logos/20070205-main_husky_logo.jpg CALGARY, ALBERTA --
Sign-up for Husky Energy Announces 2014 Second Quarter Dividend investment picks
BOISE, Idaho , July 24, 2014 /PRNewswire/ -- IDACORP, Inc. (NYSE:IDA) will report its second quarter results on Thursday, July 31 , in a news release before the stock markets open.
Sign-up for IDACORP Schedules Second Quarter Earnings Release & Conference Call investment picks
BUENA, N.J. , July 24, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic drug development and manufacturing company, announced its financial results for the second quarter ended June 30, 2014 .
Sign-up for IGI Laboratories Announces Second Quarter 2014 Results investment picks
2014/7/24
BUENA, N.J. , July 24, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has accepted Damian Finio's resignation from its Board of Directors.
Sign-up for IGI Laboratories, Inc. Announces Change To Its Board Of Directors investment picks
Diversity in the U.S. power supply—the most cost-effective means of managing the inherent risks in fuel costs and technology performance in generating power—could be dramatically reduced in coming decades, says a new study by IHS (NYSE: IHS), the leading global source of critical information and insight.
Sign-up for IHS Study: Diversity of United States Power Supply Could be Significantly Reduced in Coming Decades investment picks
2014/7/24
IIROC Trading Halt - DWI Canada NewsWire TORONTO , July 24, 2014 /CNW/ - The following issues have been halted by IIROC: Company: DragonWave Inc. TSX Symbol: DWI (all issues) Reason: Pending News Halt Time (ET): 4:15 PM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company.
Sign-up for IIROC Trading Halt - DWI investment picks
2014/7/24
HIGHLIGHTS - Operating leverage drives approximately 15% growth in adjusted net income in the second quarter compared to Q2 2013, contributing to $21.3 million in cash flow from operations in the quarter - IMAX installs 30 new theaters across 13 countries in Q2, including 12 new theaters in China - Company signs deals for 24 theater systems in the second quarter, bringing backlog to 419 theaters NEW YORK , July 24, 2014 /PRNewswire/ -- IMAX Corporation (NYSE: IMAX; TSX: IMX) today reported second quarter 2014 revenues of $79.1 million , adjusted EBITDA as calculated in accordance with the Company's credit facility of $32.8 million , adjusted net income, after non-controlling interest, of $17.2 million , or $0.25 per diluted share, and reported net income, after non-controlling interest, of $13.3 million , or $0.19 per diluted share.
Sign-up for IMAX Corporation Reports Second Quarter 2014 Financial Results investment picks
TAMPA, FL , July 24, 2014 /PRNewswire/ - iMD Companies, Inc. (OTC:ICBU) iMD Companies is pleased to announce that a group of accredited investors has signed an agreement to invest up to $500,000.00 specifically targeted at growing the Company's core Gardening business.
Sign-up for iMD Companies Inc., Receives $500,000.00 Short Term Funding Commitment from Private Investment Group investment picks
SEATTLE and SOUTH SAN FRANCISCO, Calif., July 24, 2014 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ) announced today the pricing of its initial public offering of 5,000,000 shares of its common stock at a price of $12.00 per share for an aggregate offering of $60.0 million, before underwriting discounts, commissions and expenses.
Sign-up for Immune Design Announces Pricing of Initial Public Offering investment picks
- Imprimis' proprietary ophthalmic compounded formulations now available by prescription in 32 states and territories - SAN DIEGO , July 24, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY) , a vertically-integrated specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical compounded drug formulations, announced today that two Key Opinion Leader (KOL) presentations that describe the benefits of dropless cataract surgery formulations will be delivered at the upcoming American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium in Deer Valley, Utah from July 24 – 27, 2014.
Sign-up for Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Featured in Two Sessions at the 2014 American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium investment picks
IMS Health Holdings, Inc. (“IMS Health”) (NYSE:IMS), a leading global provider of information and technology services to the healthcare and life sciences industries, today announced results for the quarter ended June 30, 2014.
Sign-up for IMS Health Reports Second-Quarter 2014 Results investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, August 5, 2014, at 8:30 a.m. ET.
Sign-up for Infinity Announces the Date of Its Second Quarter 2014 Financial Results Conference Call and Webcast investment picks
Achieved over $1 billion of revenues in a 12-month period for the first time in company history Second quarter software revenues of $103.5 million, up 13 percent year-over-year Second quarter subscription revenues of $16.2 million, up 43 percent year-over-year Second quarter GAAP earnings per diluted share of $0.20, up 25% year-over-year, and non-GAAP earnings per diluted share of $0.35, up 13% year-over-year REDWOOD CITY, Calif., July 24, 2014 (GLOBE NEWSWIRE) -- Informatica Corporation (Nasdaq:INFA) , the world's number one independent provider of data integration software, today announced financial results for the second quarter ended June 30, 2014.
Sign-up for Informatica Reports Second Quarter Revenues of $250.7 Million investment picks
2014/7/24
Data on primary efficacy endpoint Leukemia-Free Survival expected end of 2015 MARSEILLE, France, July 24, 2014 (GLOBE NEWSWIRE) -- Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH), the innate immunity company developing first-in-class drug candidates for cancer and inflammatory diseases, today announced completion of target enrollment in the EffiKIR trial with 150 patients randomized.
Sign-up for INNATE PHARMA : Completion of target enrollment in the phase II EffiKIR trial investment picks
NEW YORK , July 24, 2014 /PRNewswire/ -- Lyfebulb, the International Pemphigus Pemphigoid Foundation (IPPF) and Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm : "IMNP."; "Immune" or "the Company"), announced a collaboration to increase awareness of unmet needs in treating bullous pemphigoid last night at an event attended by more than sixty patients, physicians, scientists and other interested parties.
Sign-up for Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin investment picks
2014/7/24
Fenner Precision has developed a unique timing belt design which provides high-accuracy, low-maintenance linear motion solutions for 3D printing machines.
Sign-up for Innovative Motion Control Solutions for 3D Printing from Fenner Precision investment picks
2014/7/24
Intel Corporation's board of directors has declared a quarterly dividend of 22.5 cents per share (90 cents per share on an annual basis) on the company's common stock.
Sign-up for Intel Declares Quarterly Cash Dividend investment picks
Financial and operating highlights include: CHICAGO, July 24, 2014 (GLOBE NEWSWIRE) -- Inteliquent, Inc. (Nasdaq:IQNT) , a leading provider of voice services, today announced its financial results for the second quarter of 2014.
Sign-up for Inteliquent Reports Second Quarter Results investment picks
NEW YORK (MarketWatch) -- Shares of Interpublic Group of Companies (IPG) rallied 1.9% to a fresh 12-year high early Thursday after the advertising company said in a filing that hedge fund Elliott Associates has acquired a stake in the company.
Sign-up for Interpublic shares rise after shareholder seeks to increase value investment picks
ADVISORY, July 24, 2014 (GLOBE NEWSWIRE) -- What: Intersect ENT (Nasdaq:XENT) , a commercial drug-device company committed to improving the quality of life for patients with ear, nose and throat conditions, will visit the NASDAQ MarketSite in Times Square in celebration of its initial public offering (IPO) which will occur today, July 24, 2014.
Sign-up for Intersect ENT (NASDAQ: XENT) to Ring The NASDAQ Stock Market Opening Bell in Celebration of IPO investment picks
SUNNYVALE, Calif., July 24, 2014 (GLOBE NEWSWIRE) -- Intuitive Surgical (Nasdaq:ISRG) today announced the launch of the first annual Intuitive Surgical Robotics Fellowship Course through the American Association for Thoracic Surgery's (AATS) Graham Foundation.
Sign-up for Intuitive Surgical Supports Inaugural AATS Graham Foundation Fellowship Course investment picks
Invacare Corporation (NYSE: IVC) today announced its financial results for the quarter and six months ended June 30, 2014.
Sign-up for Invacare Corporation Announces Financial Results for the Second Quarter of 2014 investment picks
NEW YORK , July 24, 2014 /PRNewswire/ -- The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of QR Energy, LP (NYSE: QRE) ("QR Energy") in connection with the sale of the Company to Breitburn Energy Partners LP (Nasdaq: BBEP) .
Sign-up for INVESTOR ALERT - QR Energy, LP: The Law Offices of Vincent Wong Investigates the Sale of QR Energy, LP - QRE investment picks
NEW YORK , July 24, 2014 /PRNewswire/ -- The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Rockwood Holdings, Inc. (NYSE: ROC) ("Rockwood") in connection with the sale of the Company to Albemarle Corporation (NYSE: ALB) .
Sign-up for INVESTOR ALERT - Rockwood Holdings, Inc.: The Law Offices of Vincent Wong Investigates the Sale of Rockwood Holdings, Inc. - ROC investment picks
Holzer & Holzer, LLC announces that a class action lawsuit has been filed in the United States District Court for the District of Delaware on behalf of investors who purchased The Bancorp, Inc. (“Bancorp” or the “Company”) (NASDAQ: TBBK) securities between April 24, 2013 and June 10, 2014.
Sign-up for INVESTOR ALERT: Holzer & Holzer Announces Class Action Filed on Behalf of Investors in the Bancorp Inc. investment picks
Levi & Korsinsky is investigating the Board of Directors of QR Energy, LP (“QR Energy” or “the Company”) (NYSE:QRE) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Breitburn Energy Partners LP (Nasdaq:BBEP). Click here to learn more about the investigation: http://zlk.9nl.com/qr-energy-qre , or call: 877-363-5972.
Sign-up for INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of QR Energy, LP and Its Board of Directors In Connection With the Sale of the Company to Breitburn Energy LP -- QRE investment picks
SHORT HILLS, N.J. , July 24, 2014 /PRNewswire/ -- Investors Bancorp, Inc. (NASDAQ: ISBC) ("Company"), the holding company for Investors Bank ("Bank"), reported net income of $15.2 million for the three months ended June 30, 2014 compared to net income of $28.1 million for the three months ended June 30, 2013.
Sign-up for Investors Bancorp, Inc. Announces Second Quarter Financial Results and Cash Dividend investment picks
Iowa First Bancshares Corp.
Sign-up for Iowa First Bancshares Corp. Reports Second Quarter Financial Results and Dividend Payment investment picks
IPG Photonics Corporation (NASDAQ: IPGP) today announced that its Chief Financial Officer, Tim Mammen, will be presenting at Needham’s 3 rd Annual Advanced Industrial Technologies Conference on Thursday, August 7, 2014 at 2:30 p.m. ET.
Sign-up for IPG Photonics to Present at Needham 3rd Annual Advanced Industrial Technologies Conference investment picks
MOUNTAIN VIEW, Calif.
Sign-up for IRIDEX Announces Second Quarter 2014 Conference Call and Release Date investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Husky Energy Announces 2014 Second Quarter Dividend to IRIDEX Announces Second Quarter 2014 Conference Call and Release Date
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices